These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37068594)

  • 41. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
    Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
    J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
    Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
    Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
    Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women.
    Verlaan JPL; Stegeman BH; Timp JF; Scheres LJJ; Flinterman LE; Helmerhorst FM; Rosendaal FR; Cannegieter SC; van Hylckama Vlieg A
    J Thromb Haemost; 2024 Aug; 22(8):2195-2202. PubMed ID: 38554933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Martín-Martos F; Trujillo-Santos J; Del Toro J; Bura-Riviere A; Lorenzo A; Barillari G; Soler S; Mahè I; Sahuquillo JC; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S16-S20. PubMed ID: 28262228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data.
    Robin P; Le Pennec R; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Tromeur C; Planquette B; Sanchez O; Pesavento R; Filippi L; Rodger MA; Kovacs MJ; Mallick R; Salaun PY; Le Gal G
    J Thromb Haemost; 2023 Jun; 21(6):1519-1528.e2. PubMed ID: 36740040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
    Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
    Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study.
    Lai N; Jones AE; Johnson SA; Witt DM
    J Thromb Thrombolysis; 2021 Aug; 52(2):414-418. PubMed ID: 33486650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.
    Huang W; Goldberg RJ; Anderson FA; Cohen AT; Spencer FA
    J Thromb Thrombolysis; 2016 Apr; 41(3):525-38. PubMed ID: 26847621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
    Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
    J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.
    Balabanova Y; Farahmand B; Stattin P; Garmo H; Brobert G
    BMC Urol; 2022 Feb; 22(1):15. PubMed ID: 35109829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
    Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.